Drug shortages homepage

Welcome to Drug Shortages Canada, the website for mandatory reporting of drug shortages and discontinuations by market authorization holders. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.

Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, drug supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.

The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.

Ensuring people can get the medicines they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.

If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca.

Below are the newest shortage and discontinuation reports and updates to existing ones.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
TIMOPTIC ELVIUM LIFE SCIENCES Actual shortage 0.5% Updated Report 2025-12-12 267762
IMITREX GLAXOSMITHKLINE INC Actual shortage 5MG Updated Report 2025-12-12 271904
ARNUITY ELLIPTA GLAXOSMITHKLINE INC Actual shortage 100MCG Updated Report 2025-12-12 272372
TEVA-TERIFLUNOMIDE TEVA CANADA LIMITED Actual shortage 14MG Updated Report 2025-12-12 269214
TEVA-TELMISARTAN HCTZ TEVA CANADA LIMITED Actual shortage 80.0MG 25.0MG Updated Report 2025-12-12 263163
TEVA-PROPRANOLOL TEVA CANADA LIMITED Resolved 10MG Updated Report 2025-12-12 272283
TEVA-OMEPRAZOLE TEVA CANADA LIMITED Actual shortage 20MG Updated Report 2025-12-12 242358
INDIUM (111IN) OXINE SOLUTION GE HEALTHCARE CANADA INC Actual shortage 37MBq Updated Report 2025-12-12 273147
TEVA-LISINOPRIL/HCTZ (TYPE Z) TEVA CANADA LIMITED Actual shortage 25MG 20MG Updated Report 2025-12-12 270663
TEVA-LENOLTEC NO. 3 TEVA CANADA LIMITED Actual shortage 15MG 30MG 300MG Updated Report 2025-12-12 273249

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
CEFTRIAXONE SODIUM FOR INJECTION BP STERIMAX INC To be discontinued 250MG New Report 2025-12-11 274173
BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP STERIMAX INC To be discontinued 7.5MG New Report 2025-12-11 274162
TRUSOPT ELVIUM LIFE SCIENCES Discontinued 2% Updated Report 2025-12-10 267941
FIASP NOVO NORDISK CANADA INC Discontinued 100UNIT Updated Report 2025-12-08 240240
NAT-LEVETIRACETAM NATCO PHARMA (CANADA) INC Discontinued 500MG Updated Report 2025-12-06 273434